Does Fresh Frozen Plasma in Russells viper bite coagulopathy reduce the dose and duration of antivenom therapy?

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/631073

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

This proposal seeks funding to undertake a trial of clotting factor replacement with low dose antivenom therapy in snake bite coagulopathy in Sri Lanka. The aim is to determine if factor replacement will result in a rapid return of clotting function, allow a smaller dose of antivenom and therefore reduce the potential risk of major bleeding and reactions to antivenom. This study will have international implications because globally snakebite coagulopathy is a major cause of morbidity and death .

Funded Activity Details

Start Date: 01-01-2010

End Date: 01-01-2013

Funding Scheme: NHMRC Project Grants

Funding Amount: $622,344.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Toxicology (incl. Clinical Toxicology)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

ELISA | PGP3 | coagulation disorders | emergency medical service | envenomation | pharmacology - toxicology | primary health care | therapy | toxinology | venom

Related Links